Results 131 to 140 of about 68,932 (288)

Nicotinamide (Vitamin B3) Deficiency in Follicular Fluid of Patients With Ovarian Ageing

Journal of Cellular and Molecular Medicine, Volume 30, Issue 6, March 2026.
ABSTRACT Nicotinamide is an essential precursor of NAD involved in energy metabolism. A decline in NAD levels across tissues during ageing is well‐documented, and NAD metabolism has been implicated in ovarian ageing. We investigated the relationship between ovarian ageing and the levels of nicotinamide (NAM) and its metabolite 1‐methylnicotinamide (MNA)
Cinzia Bocca, Magalie Boguenet, Lisa Boucret, Pierre‐Emmanuel Bouet, Pascal Reynier, Pascale May‐Panloup   +5 more
wiley   +1 more source

Longitudinal follow-up of bone density and body composition in children with precocious or early puberty before, during and after cessation of GnRH agonist therapy [PDF]

, 2002
We studied bone mineral density (BMD), bone metabolism, and body composition in 47 children with central precocious puberty (n = 36) or early puberty (n = 11) before, during, and after cessation of GnRH agonist.
Boot, A.M. (Annemieke), Drop, S.L.S. (Stenvert), Krenning, E.P. (Eric), Muinck Keizer-Schrama, S.M.P.F. (Sabine) de, Sluis, I.M. (Inge) van der   +4 more
core  

Risk of colorectal cancer in men on long-term androgen deprivation therapy for prostate cancer [PDF]

, 2017
Background Androgen deprivation with gonadotropin-releasing hormone (GnRH) agonists or orchiectomy is a common but controversial treatment for prostate cancer.
Gillessen, Silke, Kuo, Yong-Fang, Marra, Giancarlo, Shahinian, Vahakn B., Templeton, Arnoud, Valtorta, Emanuele   +5 more
core  

Leukemia Inhibitory Factor Represses GnRH Gene Expression via cFOS during Inflammation in Male Mice. [PDF]

, 2019
BackgroundThe mechanisms whereby neuroinflammation negatively affects neuronal function in the hypothalamus are not clear. Our previous study determined that obesity-mediated chronic inflammation elicits sex-specific impairment in reproductive function ...
Coss, Djurdjica, Lainez, Nancy M
core   +1 more source

Pattern of prolactin secretion after administration of gonadotropin-releasing hormone agonist at the preovulatory phase of intrauterine insemination cycles

São Paulo Medical Journal
CONTEXT AND OBJECTIVE: Administration of a gonadotropin-releasing hormone (GnRH) agonist at the preovulatory phase is an option for triggering ovulation in assisted reproductive technology cycles.
Mario Cavagna, João Carlos Mantese, Gilberto da Costa Freitas, Artur Dzik, Jonathas Borges Soares, Yaron Hameiry, Vicente Mario Izzo, José Aristodemo Pinotti   +7 more
doaj   +1 more source

A pituitary adenoma secreting high molecular weight adrenocorticotropin without evidence of Cushing's disease [PDF]

, 1987
Allolio, B., Kaulen, D., Reincke, Martin, Saeger, W., Winkelmann, W.   +4 more
core   +1 more source

Immunoreactive inhibin in human follicular fluid in an ovarian hyperstimulation proramme for in vitro fertilisation: correlations and different forms [PDF]

, 1993
Lechner, K., Mehltretter, G., Müller, O. A., Reichardt, Bärbel, Rjosk, H. K., Schopohl, J.   +5 more
core   +1 more source

Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy.

Fertility and Sterility, 2017
M. Bedaiwy, C. Allaire, Sukinah Alfaraj
semanticscholar   +1 more source

Improvement in Myoclonus-Dystonia Syndrome during Treatment with Gonadotropin-Releasing Hormone Agonist. [PDF]

Mov Disord Clin Pract, 2023
Moura J, Magalhães M.
europepmc   +1 more source

Gonadotropin-releasing hormone agonist trigger increases the number of oocytes and embryos available for cryopreservation in cancer patients undergoing ovarian stimulation for fertility preservation.

Fertility and Sterility, 2017
N. Pereira, A. G. Kelly, Logan D. Stone, J. Witzke, J. Lekovich, R. Elias, G. Schattman, Z. Rosenwaks   +7 more
semanticscholar   +1 more source